Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Docetaxel and Sorafenib in Advanced Non-Squamous NSCLC
NCT00801801Phase 2Terminated
- Sponsor
- Francisco Robert
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by Francisco Robert. Started Jan 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00801801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801801.